Pharmanutra

Pharmanutra's reported carbon emissions

Pharmanutra, an Italian pharmaceutical preparation manufacturer, reported a total of approximately 2.4 million kg CO2e in emissions for the 2024 reporting year. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions for 2024 were approximately 220,000 kg CO2e, and Scope 2 emissions were around 1.48 million kg CO2e, with market-based accounting showing 931,000 kg CO2e and location-based accounting at 545,000 kg CO2e. Scope 3 emissions for the same year included approximately 12,100 kg CO2e for fuel and energy-related activities. In the preceding year, 2023, Pharmanutra's total emissions were approximately 2.9 million kg CO2e. Scope 1 emissions for 2023 were reported as about 229,000 kg CO2e, while Scope 2 emissions stood at approximately 457,000 kg CO2e (271,000 kg CO2e market-based and 186,000 kg CO2e location-based). Scope 3 emissions for fuel and energy-related activities were around 11,890 kg CO2e. For the 2022 reporting year, Pharmanutra's total emissions were approximately 2.88 million kg CO2e. Scope 1 emissions were about 199,000 kg CO2e, and Scope 2 emissions were around 89,000 kg CO2e (58,000 kg CO2e market-based and 31,000 kg CO2e location-based). Pharmanutra's sustainability reports indicate a commitment to climate action, with data reported for Scope 1 and Scope 2 emissions from 2020 to 2024. While specific absolute reduction targets or achievements are not detailed in the provided information, the company's reporting demonstrates a growing awareness and tracking of its environmental footprint within the pharmaceutical preparation manufacturing sector. The available data shows a fluctuating trend in total emissions across these years, with a notable increase in Scope 2 emissions in 2024. Pharmanutra has not disclosed specific SBTi reduction targets or joined climate initiatives like the Climate Pledge.